Document is current
Any future updates will be listed below
-
Authors
Bondeson, Daniel P.
Paolella, Brenton R. http://orcid.org/0000-0003-3394-828X
Asfaw, Adhana
Rothberg, Michael V.
Skipper, Thomas A.
Langan, Carly
Mesa, Gabriel
Gonzalez, Alfredo
Surface, Lauren E.
Ito, Kentaro
Kazachkova, Mariya
Colgan, William N. http://orcid.org/0000-0002-8328-4672
Warren, Allison
Dempster, Joshua M. http://orcid.org/0000-0002-3634-9576
Krill-Burger, John M. http://orcid.org/0000-0001-9614-4671
Ericsson, Maria
Tang, Andrew A.
Fung, Iris
Chambers, Emily S.
Abdusamad, Mai
Dumont, Nancy
Doench, John G. http://orcid.org/0000-0002-3707-9889
Piccioni, Federica
Root, David E. http://orcid.org/0000-0001-5122-861X
Boehm, Jesse http://orcid.org/0000-0002-6795-6336
Hahn, William C. http://orcid.org/0000-0003-2840-9791
Mannstadt, Michael
McFarland, James M. http://orcid.org/0000-0001-9978-480X
Vazquez, Francisca http://orcid.org/0000-0002-2857-4685
Golub, Todd R. http://orcid.org/0000-0003-0113-2403
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA212229, CA242457)
Novo Ventures
Slim Initiative in Genomic Medicine for the Americas Novo Ventures
- License Information
-
More Information
Article History
Received: 17 July 2020
Accepted: 4 March 2022
First Online: 18 April 2022
Competing interests
: F.V. receives research funding from Novo Holdings. D.E.R. receives research funding from the Functional Genomics Consortium (Abbvie, Jannsen, Merck and Vir) and is a director of Addgene. T.R.G. previously received cash and/or equity compensation for consulting to GlaxoSmithKline, Sherlock Biosciences and FORMA Therapeutics, is currently a paid consultant for Anji Pharmaceuticals and receives research funding from Bayer HealthCare, Calico Life Sciences and Novo Holdings. W.C.H. is a consultant for ThermoFisher, Solasta, MPM Capital, iTeos, Frontier Medicines and Paraxel and is a Scientific Founder and serves on the Scientific Advisory Board for KSQ Therapeutics. All other authors declare no competing interests.
